Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1621 1627 1638 1672
This examiner grants 58% of resolved cases
John William Lippert is an examiner in Tech Center 1600, working in Art Unit 1615. The examiner has 170 resolved cases. The allowance rate is 58.2 percent. This rate provides a baseline for the likelihood of obtaining a patent grant. The 170 resolved cases offer a sufficient data set to evaluate the examiner's performance and prosecution style.
The median days to allowance is 1214. This duration represents the typical time from filing to the issuance of a patent. The interview lift is 40.0 percent. This is a very high lift, indicating a substantial increase in the probability of allowance following an interview. When compared to the 58.2 percent allowance rate, the 40.0 percent lift highlights the extreme effectiveness of direct communication with the examiner.
In Art Unit 1615, the 40.0 percent interview lift is a key strategic consideration for practitioners. The 1214 median days to allowance provides a clear expectation for pendency. With 170 resolved cases, the examiner's 58.2 percent allowance rate is well-supported. The data strongly suggests that requesting an interview is one of the most productive steps an applicant can take to achieve a successful outcome.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18670474 | CROSSLINKED HYDROGELS WITH TUNABLE RADIOPACITY FOR MEDICAL APPLICATIONS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18841466 | TISSUE DISPLACEMENT FOAM | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18569359 | METHODS AND MATERIALS FOR COMBINING BIOLOGICS WITH MULTIPLE CHELATORS | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18290522 | USE OF ETHYNYLPYRIDINE COMPOUNDS AS NITRIFICATION INHIBITORS | Final Rejection | BASF SE |
| 18547550 | PESTICIDAL FORMULATIONS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18832026 | ANTI-B7-H3 COMPOUNDS AND METHODS OF USE | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17996618 | LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18852262 | SYSTEMS AND METHODS UTILIZING THERANOSTIC AGENTS FOR BPCT AND BNCT FOR TARGETED CANCER TREATMENT | Non-Final OA | University of Virginia Patent Foundation |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | Final Rejection | University of Virginia Patent Foundation |
| 18268472 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | Non-Final OA | CORNELL UNIVERSITY |
| 18717525 | SMALL MOLECULE TRACERS BINDING TO ALPHA-SYNUCLEIN AGGREGATES AND THEIR USES | Non-Final OA | Fudan University |
| 18332826 | Monolithic Implantable Device for Sustained Release of an Antibody | Non-Final OA | Celanese EVA Performance Polymers LLC |
| 18549702 | Nanofiber- and Nanowhisker-Based Transfection Platforms for Bulk Electroporation | Final Rejection | Nanofiber Solutions, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy